International Journal of Alzheimer’s Disease

Biomarkers for Dementia


Publishing date
01 Jun 2011
Status
Published
Submission deadline
01 Dec 2010

Lead Editor

1Department of Biological Regulation, Faculty of Medicine, Tottori University, Yonago, Tottori 680-8550, Japan

2Department of Geriatrics and Gerontology, Division of Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan

3Transitional Medicine, Pfizer Global Research and Development Eastern Pt, Road, Groton, CT 06340, USA

4Laboratorio di Epidemiologia, Neuroimaging e Telemedicina, IRCCS Centro San Giovanni di Dio FBF, Via Pilastroni 1, Brescia, Italy


Biomarkers for Dementia

Description

The development of treatments for dementia is advancing with steady steps, and early diagnosis is considered critical. Biomarkers are central components of drug development in Alzheimer's disease and related disorders including dementia with lewy bodies, frontotemporal dementia, and vascular dementia, and so forth. Therefore, we would like to focus upon biomarkers as the theme.

We invite authors to submit original research and review articles about biomarkers for Alzheimer's disease and related disorders including dementia with lewy bodies, frontotemporal dementia, and vascular dementia in basic and clinical research. Potential topics include, but are not limited to:

  • Recent developments of genetic testing
  • Advances of structural imaging (CT, MRI, etc.)
  • Advances of functional imaging (SPECT, PET, Amyloid imaging, etc.)
  • Recent developments of peripheral markers (cerebrospinal fluid, serum, fibroblast, etc.)
  • Role of new biomarkers for disease modifying therapies

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2011
  • - Article ID 503293
  • - Review Article

Diagnostic Utility of CSF Tau and A 𝜷 𝟒 𝟐 in Dementia: A Meta-Analysis

Rachna Agarwal | Chandra Bhushan Tripathi
  • Special Issue
  • - Volume 2011
  • - Article ID 572495
  • - Review Article

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease

Seema Patel | Raj J. Shah | ... | Marwan Sabbagh
  • Special Issue
  • - Volume 2011
  • - Article ID 598175
  • - Review Article

Biomarkers to Measure Treatment Effects in Alzheimer's Disease: What Should We Look for?

Kenneth Rockwood
  • Special Issue
  • - Volume 2011
  • - Article ID 352787
  • - Research Article

High Throughput ELISAs to Measure a Unique Glycan on Transferrin in Cerebrospinal Fluid: A Possible Extension toward Alzheimer's Disease Biomarker Development

Keiro Shirotani | Satoshi Futakawa | ... | Yasuhiro Hashimoto
  • Special Issue
  • - Volume 2011
  • - Article ID 762471
  • - Research Article

Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population

Nobuto Shibata | Tohru Ohnuma | ... | Heii Arai
  • Special Issue
  • - Volume 2011
  • - Article ID 842475
  • - Review Article

Bridging Molecular Genetics and Biomarkers in Lewy Body and Related Disorders

Gilbert J. Ho | Willie Liang | ... | Makoto Hashimoto
  • Special Issue
  • - Volume 2011
  • - Article ID 546871
  • - Research Article

Joint Assessment of Structural, Perfusion, and Diffusion MRI in Alzheimer's Disease and Frontotemporal Dementia

Yu Zhang | Norbert Schuff | ... | Michael W. Weiner
  • Special Issue
  • - Volume 2011
  • - Article ID 914085
  • - Research Article

Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD

Simon Duchesne | Abderazzak Mouiha
  • Special Issue
  • - Volume 2011
  • - Article ID 208218
  • - Research Article

Volumetric Differences in Mapped Hippocampal Regions Correlate with Increase of High Alpha Rhythm in Alzheimer's Disease

D. V. Moretti | A. Prestia | ... | G. B. Frisoni
  • Special Issue
  • - Volume 2011
  • - Article ID 535816
  • - Review Article

The Default Mode Network in Healthy Aging and Alzheimer's Disease

Katell Mevel | Gaël Chételat | ... | Béatrice Desgranges
International Journal of Alzheimer’s Disease
 Journal metrics
Acceptance rate17%
Submission to final decision100 days
Acceptance to publication36 days
CiteScore3.800
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.